 | • レポートコード：MRC2304A044 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、239ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療 |
| Single User（1名利用、印刷可） | ￥717,605 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,442,605 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社は、2021年に897.21百万ドルであった世界の予測遺伝学市場規模が2022年に1,058.98百万ドルに到達し、2027年までにCAGR 18.20％で成長して2,447.68百万ドルへと拡大すると予測しています。当調査資料では、予測遺伝学の世界市場について多角的な視点から分析を行い、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、種類別（素因検査、発症前検査）分析、デモグラフィック別（35～64歳、65歳以上、35歳以下）分析、検査種類別（人口スクリーニング、感受性検査）分析、施設別（クリニック、D2C（消費者直接）、病院）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況、企業情報などの項目をまとめました。なお、当書内の企業情報としては、23andMe、Color Genomics、CRISPR Therapeutics、Deep Genomics Inc.、Editas Medicine、Futura Genetics、Gene by Gene、Intellia Therapeutics、Laboratory Corporation of America、Mapmygenome India、MyDNA、Myriad Genetics、Positive Bioscience、Quest Diagnostics, Inc.、Veritas Geneticsなどが掲載されています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の予測遺伝学市場規模：種類別 - 素因検査の市場規模 - 発症前検査の市場規模 ・世界の予測遺伝学市場規模：デモグラフィック別 - 35～64歳における市場規模 - 65歳以上における市場規模 - 35歳以下における市場規模 ・世界の予測遺伝学市場規模：検査種類別 - 人口スクリーニングの市場規模 - 感受性検査の市場規模 ・世界の予測遺伝学市場規模：施設別 - クリニックにおける市場規模 - D2C（消費者直接）における市場規模 - 病院における市場規模 ・世界の予測遺伝学市場規模：地域別 - 南北アメリカの予測遺伝学市場規模 アメリカの予測遺伝学市場規模 カナダの予測遺伝学市場規模 ブラジルの予測遺伝学市場規模 ... - アジア太平洋の予測遺伝学市場規模 日本の予測遺伝学市場規模 中国の予測遺伝学市場規模 インドの予測遺伝学市場規模 韓国の予測遺伝学市場規模 台湾の予測遺伝学市場規模 ... - ヨーロッパ/中東/アフリカの予測遺伝学市場規模 イギリスの予測遺伝学市場規模 ドイツの予測遺伝学市場規模 フランスの予測遺伝学市場規模 ロシアの予測遺伝学市場規模 ... - その他地域の予測遺伝学市場規模 ・競争状況 ・企業情報 |
The Global Predictive Genetics Market size was estimated at USD 897.21 million in 2021 and expected to reach USD 1,058.98 million in 2022, and is projected to grow at a CAGR 18.20% to reach USD 2,447.68 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Predictive Genetics to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Type, the market was studied across Predispositional testing and Presymptomatic testing.
Based on Demographics, the market was studied across 35 – 64, 65+, and <35. Based on Test Type, the market was studied across Population Screening and Susceptibility. Based on Setting Type, the market was studied across Clinic, Direct to Consumer, and Hospital. Based on Application, the market was studied across Cancer, Cardiovascular Disease, and Genetic Disease. Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. Cumulative Impact of COVID-19: COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market. Cumulative Impact of 2022 Russia Ukraine Conflict: We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Predictive Genetics market considering the current update on the conflict and its global response. Competitive Strategic Window: The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period. FPNV Positioning Matrix: The FPNV Positioning Matrix evaluates and categorizes the vendors in the Predictive Genetics Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape. Market Share Analysis: The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits. Competitive Scenario: The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service. Company Usability Profiles: The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Predictive Genetics Market, including 23andMe, Color Genomics, CRISPR Therapeutics, Deep Genomics Inc., Editas Medicine, Futura Genetics, Gene by Gene, Intellia Therapeutics, Laboratory Corporation of America, Mapmygenome India, MyDNA, Myriad Genetics, Positive Bioscience, Quest Diagnostics, Inc., and Veritas Genetics. The report provides insights on the following pointers: 1. Market Penetration: Provides comprehensive information on the market offered by the key players 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments The report answers questions such as: 1. What is the market size and forecast of the Global Predictive Genetics Market? 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Predictive Genetics Market during the forecast period? 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Predictive Genetics Market? 4. What is the competitive strategic window for opportunities in the Global Predictive Genetics Market? 5. What are the technology trends and regulatory frameworks in the Global Predictive Genetics Market? 6. What is the market share of the leading vendors in the Global Predictive Genetics Market? 7. What modes and strategic moves are considered suitable for entering the Global Predictive Genetics Market?
レポート目次1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing use of emerging technologies to gain valuable insights
5.1.1.2. Adopted for new and growing class of medical tests, differing in fundamental ways from conventional medical diagnostic tests
5.1.1.3. Reduces the risk of a specific condition will lead to reduced morbidity and mortality through targeted screening, surveillance, and prevention
5.1.2. Restraints
5.1.2.1. Lack of skilled workforce
5.1.3. Opportunities
5.1.3.1. Need of genetic predisposition DNA testing for type 2 diabetes and
5.1.3.2. Rising investment and R&D in gene manipulation
5.1.4. Challenges
5.1.4.1. Companies’ concern over data security and privacy issues
5.2. Cumulative Impact of COVID-19
6. Predictive Genetics Market, by Type
6.1. Introduction
6.2. Predispositional testing
6.3. Presymptomatic testing
7. Predictive Genetics Market, by Demographics
7.1. Introduction
7.2. 35 – 64
7.3. 65+
7.4. <35
8. Predictive Genetics Market, by Test Type
8.1. Introduction
8.2. Population Screening
8.3. Susceptibility
9. Predictive Genetics Market, by Setting Type
9.1. Introduction
9.2. Clinic
9.3. Direct to Consumer
9.4. Hospital
10. Predictive Genetics Market, by Application
10.1. Introduction
10.2. Cancer
10.3. Cardiovascular Disease
10.4. Genetic Disease
11. Americas Predictive Genetics Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Predictive Genetics Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Predictive Genetics Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.1.1. Quadrants
14.1.2. Business Strategy
14.1.3. Product Satisfaction
14.2. Market Ranking Analysis, By Key Player
14.3. Market Share Analysis, By Key Player
14.4. Competitive Scenario
14.4.1. Merger & Acquisition
14.4.2. Agreement, Collaboration, & Partnership
14.4.3. New Product Launch & Enhancement
14.4.4. Investment & Funding
14.4.5. Award, Recognition, & Expansion
15. Company Usability Profiles
15.1. 23andMe
15.1.1. Business Overview
15.1.2. Key Executives
15.1.3. Product & Services
15.2. Color Genomics
15.2.1. Business Overview
15.2.2. Key Executives
15.2.3. Product & Services
15.3. CRISPR Therapeutics
15.3.1. Business Overview
15.3.2. Key Executives
15.3.3. Product & Services
15.4. Deep Genomics Inc.
15.4.1. Business Overview
15.4.2. Key Executives
15.4.3. Product & Services
15.5. Editas Medicine
15.5.1. Business Overview
15.5.2. Key Executives
15.5.3. Product & Services
15.6. Futura Genetics
15.6.1. Business Overview
15.6.2. Key Executives
15.6.3. Product & Services
15.7. Gene by Gene
15.7.1. Business Overview
15.7.2. Key Executives
15.7.3. Product & Services
15.8. Intellia Therapeutics
15.8.1. Business Overview
15.8.2. Key Executives
15.8.3. Product & Services
15.9. Laboratory Corporation of America
15.9.1. Business Overview
15.9.2. Key Executives
15.9.3. Product & Services
15.10. Mapmygenome India
15.10.1. Business Overview
15.10.2. Key Executives
15.10.3. Product & Services
15.11. MyDNA
15.11.1. Business Overview
15.11.2. Key Executives
15.11.3. Product & Services
15.12. Myriad Genetics
15.12.1. Business Overview
15.12.2. Key Executives
15.12.3. Product & Services
15.13. Positive Bioscience
15.13.1. Business Overview
15.13.2. Key Executives
15.13.3. Product & Services
15.14. Quest Diagnostics, Inc.
15.14.1. Business Overview
15.14.2. Key Executives
15.14.3. Product & Services
15.15. Veritas Genetics
15.15.1. Business Overview
15.15.2. Key Executives
15.15.3. Product & Services
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing